"I have worked with Yvanne Enever and the PHARMExcel team for several years on a complex, multicentre clinical trial. I have found the PHARMExcel team to be efficient, highly professional while being accommodating and very supportive. I have worked with other clinical trial research organisations on similar studies and PHARMExcel have been by far the most effective in achieving targets and the easiest to work with on a day to day basis. They are very interactive and excellent in communicating with clinical teams. They have a thorough understanding of the regulatory requirements for managing GCP compliant clinical trials. I have no hesitation in recommending them as a CRO, in fact we are currently planning a new clinical trial with PHARMExcel to start in 2020."
Dr Kim Orchard
Senior Lecturer and Consultant Haematologist
University Hospital Southampton NHSFT
"Yvanne and her team at Pharmexcel are the best team I’ve worked with in clinical research. They are talented and committed individuals with great expertise in the regulatory landscape as well as delivery of clinical trials. Highly recommended!"
Dr Gautam Mehta
"PHARMExcel came in to help my team finalize an UK study. Yvanne Enever and her people formed a capable, competent, and efficient partner in this process and were quick to start and pick up the pace. Provided great support and knowledge about UK clinical trial legislation and IRB process"
Director Clinical Operation
"It has been a pleasure working with Yvanne and the team. Pharmexcel have been able to work with our clinical research teams to provide bespoke support for a number of trials, including phase 1 trials: the personal approach and attention to detail have given us confidence to ensure patient safety and manage the risks of the Trust acting as Sponsor in particular for the early phase trials"
Prof Saul Faust-Sponsor
"PHARMExcel’s passion for their projects, the professionalism shown by the team, combined with direct access to the CEO sets PHARMExcel apart from other CROs"
"We have worked in partnership with PHARMexcel to deliver one of the AGILE candidate specific trials (CST-6) in the UK. AGILE is the UK’s early phase platform trial for COVID-19 and CST-6 is a first in human multiple ascending dose study, prioritised by the UKs Antiviral Taskforce. The trial is almost complete, and whilst challenging in going directly into hospitalised COVID-19 patients, the support from PHARMexcel has been extremely high quality. This includes all aspects trial development, management and monitoring, that was also evidenced by a recent sponsor audit. We look forward to working with PHARMexcel going forwards."
CST-6 Candidate Chief Investigator
Director Global Health Trials Unit
Liverpool School of Tropical Medicine
Contact us today
We know that successful partnerships can only be advanced where there is a true understanding of requirements and expectations. PHARMExcel welcome the opportunity to learn more about your specific needs so we can best determine the right delivery approach for you.